View Document Preview and Link Document Date: 2011-01-20 15:41:22 Open Document File Size: 423,72 KB Share Result on Facebook
City Reference / / Facility Laboratory Investigations / Laboratory Test Interactions / / IndustryTerm insertion site / therapy for localized disease / food / treatment of advanced prostate cancer / implantation device / treatment for patients with prostate cancer / incision site / / MedicalCondition histiocytic sarcomas / vertebral metastases / mammary-gland adenocarcinomas / testicular Leydig-cell tumors / Injury / Poisoning / hypersensitivity / Anaphylactic reactions / prostate cancer / neck pain / pruritus / back pain / Hepatic insufficiency / local infections / gynecomastia / Nutrition Disorders / ureteral obstruction / paralysis / pancreatic islet-cell adenomas / advanced prostate cancer / hypotrichosis / tumors / disease / Nervous System Disorders / Flushing / Arthralgia / sudden cardiac death / Dyspnea / hematuria / Carcinogenesis / Hyperglycemia / bladder outlet obstruction / stomach papillomas / localized disease / Cardiovascular disease / diabetes / erythema / C disease / lethargy / patient developed erythema / pain / Renal Insufficiency / myocardial infarction / D disease / diabetes mellitus / pituitary adenomas / spinal cord compression / hypercalcemia / infection / Dizziness / renal failure / chronic / subcutaneous administration / Depression / spontaneous abortion / paresthesia / Disorders / / MedicalTreatment drug delivery system / incision / antibiotics / hormonal therapy / / Position General / PRECAUTIONS General / / Product testosterone / Vantas / / ProvinceOrState Newfoundland / / Technology drug metabolism / X-ray / diagnostic tests / ultrasound / Geriatrics / PHARMACOKINETICS / drug delivery system / / SocialTag 
Vantas™ (histrelin implant) DESCRIPTION Vantas™ (histrelin implant) is a sterile non-biodegradable, diffusion-controlled reservoir drug delivery system designed to deliver histrelin continuously for 12 months upon su